Memorandum from NZSG
Posted Thursday April 6, 2023
The NZSG Working Group for IBD Medication after discussion with NZSG members, Pharmac and pharmaceutical company representatives have written an e-guidance document on ustenkinumab treatment and ongoing maintenance doses. Please find this on the NZSG website.
Gallery
Related Articles
Pharmac Decision to fully fund oral nutrition replacements
Monday July 21, 2025
Pharmac is fully funding two liquid nutrition replacements for adults with Crohn’s disease effective from 1 July 2025.
Informative Articles in Digestive Diseases and Sciences – Vol. 70, Issue 5 (May 2025)
Monday June 9, 2025
Digestive Diseases and Sciences released its May 2025 issue—Volume 70, Issue 5 It includes a Special Issue titled “Evalu...
NZSG is on LinkedIn
Monday June 9, 2025
We're proud to announce we've joined the LinkedIn network follow us!